GE HealthCare To Acquire Intelligent Ultrasound Group's Clinical Artificial Intelligence Business For $51M

7/18/24 3:32:29 AM ET

Medical Electronics

Health Care

Get the next $GEHC alert in real time by email

GE HealthCare (NASDAQ:GEHC) today announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC's (Intelligent Ultrasound) clinical artificial intelligence (AI) software business for total consideration of approximately $51 million. Intelligent Ultrasound is a leader in integrated AI-driven image analysis tools designed to make ultrasound smarter and more efficient. GE HealthCare plans to incorporate these solutions across the ultrasound portfolio, strengthening its capabilities with technology that helps improve workflows and enhance ease-of-use for the benefit of clinicians and patients.

Get the next $GEHC alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GEHC

Date	Price Target	Rating	Analyst
9/26/2024	$84.00 → $74.00	Neutral → Sell	UBS
9/18/2024	$100.00	Neutral → Buy	BTIG Research
9/9/2024	$90.00	Neutral	JP Morgan
8/6/2024	$100.00	Buy	Stifel
5/30/2024	$87.00	Neutral	Goldman
2/15/2024	$100.00	Buy	HSBC Securities
2/12/2024	$66.00 → $88.00	Sell → Neutral	UBS
11/30/2023	$80.00	Hold	Jefferies

More analyst ratings

$GEHC
Market Insights

Live Market Insights

GE HealthCare Selects AWS As Strategic Cloud Provider To Develop Foundation Models And Generative AI Applications For Enhanced Medical Diagnostics And Patient Care; Collaboration Aims To Improve Workflow Efficiency, Diagnostic Accuracy, And Equitable Access In Healthcare
7/25/24 8:47:12 AM ET
$AMZN
$GEHC
Catalog/Specialty Distribution
Consumer Discretionary
Medical Electronics
Health Care
GE HealthCare To Acquire Intelligent Ultrasound Group's Clinical Artificial Intelligence Business For $51M
GE HealthCare (NASDAQ:GEHC) today announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC's (Intelligent Ultrasound) clinical artificial intelligence (AI) software business for total consideration of approximately $51 million. Intelligent Ultrasound is a leader in integrated AI-driven image analysis tools designed to make ultrasound smarter and more efficient. GE HealthCare plans to incorporate these solutions across the ultrasound portfolio, strengthening its capabilities with technology that helps improve workflows and enhance ease-of-use for the benefit of clinicians and patients.
7/18/24 3:32:29 AM ET
$GEHC
Medical Electronics
Health Care
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. Here's the list of options activity happening in today's session: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume PFE CALL SWEEP BEARISH 07/19/24 $28.00 $72.8K 28.1K 2.7K MRK CALL SWEEP BEARISH 07/19/24 $140.00 $78.
6/25/24 1:35:24 PM ET
$ABBV
$GEHC
$GILD
$LLY
Biotechnology: Pharmaceutical Preparations
Health Care
Medical Electronics
Biotechnology: Biological Products (No Diagnostic Substances)

GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
Company updates medium-term framework with progress toward financial goals; increases quarterly cash dividend by approximately 17% GE HealthCare (NASDAQ:GEHC) will host its Investor Day today at Nasdaq MarketSite in New York, NY. The event begins at 8:00 am ET / 7:00 am CT and can be viewed virtually here. Registration is required for in-person attendance. The event will feature presentations from GE HealthCare President and CEO Peter Arduini, GE HealthCare Vice President and CFO Jay Saccaro, and other members of the management team, who will discuss the company's vision and precision care strategy, progress since its spin-off from General Electric Company in 2023, and key growth areas.
11/21/24 6:00:00 AM ET
$GEHC
Medical Electronics
Health Care
GE HealthCare reports third quarter 2024 financial results
Revenue growth was 1% year-over-year; Organic revenue growth* was 1% Net income margin was 9.7% versus 7.8% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 16.3% versus 15.4% Diluted earnings per share (EPS) were $1.02 versus $0.83 for the prior year; Adjusted EPS* was $1.14 versus $0.99 Cash flow from operating activities was $742 million versus $650 million for the prior year; Free cash flow* was $651 million versus $570 million Company raises low end of full-year 2024 Adjusted EBIT margin* and Adjusted EPS* guidance with continued execution; trending toward the lower end of Organic revenue growth* range GE HealthCare (NASDAQ:GEHC) today repor
10/30/24 6:20:00 AM ET
$GEHC
Medical Electronics
Health Care
GE HealthCare to announce third quarter 2024 results on October 30, 2024
GE HealthCare (NASDAQ:GEHC) will announce its third quarter 2024 financial results before the market opens on Wednesday, October 30, 2024. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions inno
10/8/24 8:00:00 AM ET
$GEHC
Medical Electronics
Health Care

GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
Company updates medium-term framework with progress toward financial goals; increases quarterly cash dividend by approximately 17% GE HealthCare (NASDAQ:GEHC) will host its Investor Day today at Nasdaq MarketSite in New York, NY. The event begins at 8:00 am ET / 7:00 am CT and can be viewed virtually here. Registration is required for in-person attendance. The event will feature presentations from GE HealthCare President and CEO Peter Arduini, GE HealthCare Vice President and CFO Jay Saccaro, and other members of the management team, who will discuss the company's vision and precision care strategy, progress since its spin-off from General Electric Company in 2023, and key growth areas.
11/21/24 6:00:00 AM ET
$GEHC
Medical Electronics
Health Care
Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue
Published in the Journal of Clinical Anesthesia, results from the two-phase, 250 patient pilot study show clinicians found a majority (82%) of the alarms from the wireless and wearable Portrait Mobile monitoring solution to be informative or useful to optimize patient care in medical-surgical units.1 Study findings suggest that continuous monitoring helps provide critical information to clinicians, enabling them to intervene effectively before a patient deteriorates. Undetected patient deterioration, particularly post-surgery, can lead to hazardous yet preventable consequences, with 30-day mortality after surgery representing the third leading cause of death globally.2 GE HealthCa
11/18/24 8:00:00 AM ET
$GEHC
Medical Electronics
Health Care
GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System
New MRI technology aims to advance neuroimaging and biomarker research GE HealthCare (NASDAQ:GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. This system offers new capabilities for both clinical imaging and neuroscience with the potential to aid in the detection of neurological, oncological, and psychiatric conditions. The FDA clearance of SIGNA MAGNUS underscores the advances made by GE HealthCare in neuroimaging. It features an innovative asymmetrical, high-efficiency, head-only gradient coil design, which achieves higher gradient performance due to its reduced inner diameter, spe
11/13/24 8:00:00 AM ET
$GEHC
Medical Electronics
Health Care

GE HealthCare To Acquire Intelligent Ultrasound Group's Clinical Artificial Intelligence Business For $51M

Chat with this insight

Recent Analyst Ratings for $GEHC

$GEHC Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Jimenez Frank R bought $100,624 worth of shares (1,315 units at $76.52), increasing direct ownership by 2% to 75,796 units (SEC Form 4)

$GEHC Market Insights

Live Market Insights

GE HealthCare Selects AWS As Strategic Cloud Provider To Develop Foundation Models And Generative AI Applications For Enhanced Medical Diagnostics And Patient Care; Collaboration Aims To Improve Workflow Efficiency, Diagnostic Accuracy, And Equitable Access In Healthcare